View in EDS HTML Full Text PDF Full Text

Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.

Saved in:
Bibliographic Details
Title: Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply.
Authors: Reenaers C, Louis E, Belaiche J, Seidel L, Keshav S, Travis S
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2013 Apr; Vol. 37 (7), pp. 752-3.
Publication Type: Letter; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.12245